According to market research future, the Vascular Graft Market would increase USD 5.9 billion at a CAGR of 7 % between 2023 and 2032. 

The Vascular Grafts Market has witnessed significant growth in recent years, driven by the increasing prevalence of cardiovascular diseases and the rising demand for advanced surgical procedures. One of the key segments contributing to this growth is coronary artery bypass grafting (CABG). CABG is a widely performed surgical intervention for treating coronary artery disease, wherein vascular grafts play a crucial role.

Coronary artery bypass grafting involves the use of vascular grafts to create a new pathway for blood flow, bypassing blocked or narrowed coronary arteries. This procedure helps improve blood supply to the heart muscle, reducing the risk of heart attacks and other cardiovascular complications. The demand for coronary artery bypass grafting procedures has surged, fueled by the global rise in lifestyle-related diseases and an aging population.

One of the prominent players in the vascular grafts market is Hemashield. Hemashield grafts, manufactured by Maquet, a Getinge company, are widely recognized for their high quality and performance in vascular surgeries. These grafts are commonly used in coronary artery bypass grafting procedures, providing surgeons with a reliable and durable solution for vascular reconstruction.

Major Key Major Key Players:

The vascular graft companies are Gore Medical (US), Cardinal Health (US), C. R. Bard (US), Terumo (Japan), LeMaitre Vascular (US), Medtronic (Ireland), Endologix (US), B. Braun Melsugen AG (Germany), Cook Medical (US), and Maquet (Germany).

Segment Analysis

The global vascular graft market has been segmented on the basis of indication, raw material, and end-user.

By mode of raw material, the global vascular graft market has been segmented into EPTFE grafts, polyester grafts, biosynthetic grafts, and polyurethane grafts, synthetic vascular grafts. Among these, the polyester grafts segment is considered to command the major share in the global market. The growth can be ascribed to the surging demand for polyester material based grafts due to its several benefits like porousness, high patency, and long lifespan.

By mode of indication, the global vascular graft market has been segmented into peripheral vascular repair, endovascular aneurysm repair, and hemodialysis access.  Among these, the endovascular aneurysm repair segment is likely to occupy the major share in the global market. The growth can be ascribed to the increased demand for endovascular aneurysms repair procedures.

By mode of end-user, the global vascular graft market has been segmented into ambulatory surgical centers and hospitals. Among these, the hospitals segment is likely to command the major share owing to the increased number of minimally invasive surgical processes in hospitals coupled with the favorable reimbursement policies especially in the developed economies.

Regional Analysis

Geographically, the vascular graft market span across regions namely, Europe, America, Asia-Pacific, and the Middle East & Africa.

Considering the global scenario, the American region is likely to dominate the global market and is likely to retain its pole position in the coming years. North America in this region is the bigger market and is likely to expand its regional market owing to the continuous support from the government for R&D activities. The presence of top market players, high availability of advanced medical facilities, surging incidences of cardiovascular diseases, chronic kidney disease, and diabetes, and the presence of high reimbursement policies are likely to contribute to the market growth in this region.

The European region occupies a significant share in the global market owing to the presence of a well-established healthcare sector. Governments in this region are highly funding for R&D activities which is further supporting its growth. Moreover, the presence of top market players, and the high availability of advanced medical facilities has further encouraged the market’s growth in this region.

The Asia Pacific region is likely to emerge as the fastest expanding market owing to the increased prevalence of diabetes and cardiovascular ailments. The improving healthcare infrastructure, surging demand for minimally invasive grafting processes, and epidemiological transition causing premature death are likely to encourage the market growth during the appraisal period.

Related Report 

Medical Holography Market

ADHD Therapeutics Market

Health Supplements Market

Pituitary cancer Market

Astigmatism Market

Purpura treatment Market

Krabbe Disease Treatment Market

Spinal Implants Market